11/11/2017 07:00:00

Vostok Emerging Finance Ltd’s Nomination Committee

Related content
27 Aug - 
Vostok Emerging Finance depository receipt buy-back
22 Aug - 
Financial report for the second quarter and six-months ..
15 Aug - 
Vostok Emerging Finance to release Six Months Report We..

Vostok Emerging Finance Ltd (Vostok Emerging Finance) is pleased to announce the composition of the Nomination Committee for the 2018 Annual General Meeting

The Nomination Committee for the 2018 AGM has been appointed in accordance with the principles resolved by the 2017 Annual General Meeting. The members of the Nomination Committee are:

 

-        Vipul Pandey, appointed by Libra Advisors;

-        Evert Carlsson, appointed by Swedbank Robur Fonder;

-        Jake Hennemuth, appointed by Ruane Cunniff & Goldfarb; and

-        Lars O Grönstedt, Chairman of the Board of Directors of Vostok Emerging Finance

 

As per the resolution of the 2017 Annual General Meeting, the task of the Nomination Committee is to make recommendations to the 2018 Annual General Meeting regarding the following matters:

 

1.     Election of Chairman for the Annual General Meeting

2.     Election of directors

3.     Election of the Chairman of the Board of Directors

4.     Remuneration to the Directors

5.     Election of the Company’s auditors

6.     Compensation to the Company’s auditors, and

7.     Proposal for how to conduct the nomination process for the 2019 Annual General Meeting.

 

Shareholders who wish to present a motion to the Annual General Meeting regarding the above-mentioned issues are requested to contact the Chairman of the Nomination Committee through e-mail at nominationcommittee@vostokemergingfinance.com no later than February 11th, 2018.

 

For further information please contact:

Henrik Stenlund, CFO, Tel +46 (0)8 545 015 50

Vostok Emerging Finance is an investment company with the goal of investing in early stage modern financial services companies across emerging and frontier markets. VEF trades in Sweden on Nasdaq First North under the ticker VEMF SDB.

Vostok Emerging Finance’s Certified Adviser on Nasdaq First North is Pareto Securities AB.

The information was submitted for publication, through the agency of the contact person set out above, at 08.00 CEST on November 11, 2017.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

HSBC Bank Plc : Form 8.5 (EPT/RI) - Lonmin PLC

22/02/2018 10:54:53
FORM 8.5 EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Name of exempt principal trader: HSBC BANK PLC (b) Name of offeror/offeree i..

Rathbone Brothers Plc : Preliminary announcement of 2017 results

22/02/2018 07:00:19
Funds under management up 14.3% to £39.1 billionThis is a preliminary statement of annual results published in accordance with FCA Listing Rule 9.7A. It covers the year ended 31 December 2017. Mark Nicholls, Chairman of Rathbone Brothers Plc, said: "UK and global investment markets performed well in 2017, with some indices reaching record levels towards the end of the year. This outcome has b..

Elliott Capital Advisors, L.P : Form 8.3 - GKN Plc

Related news
21/02/2018 15:25:10
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Elliott Capital Advisors, L.P. (for itself and related general partners ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
OpGen Partnering with New York State Department of Health and Merck’s ILÚM Health Solutions to Detect Antimicrobial-Resistant Infections
2
Youth INC and RBC Host Fourth Annual Community Event and Raise $1.7M for NYC Youth
3
Roche announces global availability of blood-based genomic profiling test, FoundationOne Liquid
4
Diagnostic Superiority and Equivalence to Biopsy: a Study Confirms the Clinical Value of ShearWave® Elastography (SWE™) for the Non-Invasive Evaluation of Liver Fibrosis
5
BrainChip to present at TechKnow Invest Roadshow

Related stock quotes

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
24 September 2018 21:11:56
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180919.1 - EUROWEB2 - 2018-09-24 22:11:56 - 2018-09-24 21:11:56 - 1000 - Website: OKAY